Literature DB >> 20578023

Reproducibility and correlation between quantitative and semiquantitative dynamic and intrinsic susceptibility-weighted MRI parameters in the benign and malignant human prostate.

Roberto Alonzi1, N Jane Taylor, J James Stirling, James A d'Arcy, David J Collins, Michele I Saunders, Peter J Hoskin, Anwar R Padhani.   

Abstract

PURPOSE: To assess the reproducibility of relaxivity- and susceptibility-based dynamic contrast-enhanced magnetic resonance imaging (MRI) in the benign and malignant prostate gland and to correlate the kinetic parameters obtained.
MATERIALS AND METHODS: Twenty patients with prostate cancer underwent paired scans before and after androgen deprivation therapy. Quantitative parametric maps for T(1)- and T(2)*-weighted parameters were calculated (K(trans), k(ep),v(e), IAUC(60), rBV, rBF, and R(2)*). The reproducibility of and correlation between each parameter were determined using standard methods at both timepoints.
RESULTS: T(1)-derived parameters are more reproducible than T(2)*-weighted measures, both becoming more variable following androgen deprivation (variance coefficients for prostate K(trans) and rBF increased from 13.9%-15.8% and 42.5%-90.8%, respectively). Tumor R(2)* reproducibility improved after androgen ablation (23.3%-11.8%). IAUC(60) correlated strongly with K(trans), v(e), and k(ep) (all P < 0.001). R(2)* did not correlate with other parameters.
CONCLUSION: This study is the first to document the variability and repeatability of T(1)- and T(2)*-weighted dynamic MRI and intrinsic susceptibility-weighted MRI for the various regions of the human prostate gland before and after androgen deprivation. These data provide a valuable source of reference for groups that plan to use dynamic contrast-enhanced MRI or intrinsic susceptibility-weighted MRI for the assessment of treatment response in the benign or malignant prostate. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20578023     DOI: 10.1002/jmri.22215

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  22 in total

Review 1.  Functional MRI for radiotherapy dose painting.

Authors:  Uulke A van der Heide; Antonetta C Houweling; Greetje Groenendaal; Regina G H Beets-Tan; Philippe Lambin
Journal:  Magn Reson Imaging       Date:  2012-07-06       Impact factor: 2.546

Review 2.  Blood-brain barrier imaging in human neuropathologies.

Authors:  Ronel Veksler; Ilan Shelef; Alon Friedman
Journal:  Arch Med Res       Date:  2014-11-29       Impact factor: 2.235

3.  Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer clinical trials: potential roles and possible pitfalls.

Authors:  Fiona M Fennessy; Rana R McKay; Clair J Beard; Mary-Ellen Taplin; Clare M Tempany
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

4.  Comparison of region-of-interest-averaged and pixel-averaged analysis of DCE-MRI data based on simulations and pre-clinical experiments.

Authors:  Dianning He; Marta Zamora; Aytekin Oto; Gregory S Karczmar; Xiaobing Fan
Journal:  Phys Med Biol       Date:  2017-09-05       Impact factor: 3.609

5.  Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection.

Authors:  Xin Li; Ryan A Priest; William J Woodward; Ian J Tagge; Faisal Siddiqui; Wei Huang; William D Rooney; Tomasz M Beer; Mark G Garzotto; Charles S Springer
Journal:  Magn Reson Med       Date:  2012-03-27       Impact factor: 4.668

6.  A novel anthropomorphic flow phantom for the quantitative evaluation of prostate DCE-MRI acquisition techniques.

Authors:  Silvin P Knight; Jacinta E Browne; James F Meaney; David S Smith; Andrew J Fagan
Journal:  Phys Med Biol       Date:  2016-10-03       Impact factor: 3.609

Review 7.  Methods and challenges in quantitative imaging biomarker development.

Authors:  Richard G Abramson; Kirsteen R Burton; John-Paul J Yu; Ernest M Scalzetti; Thomas E Yankeelov; Andrew B Rosenkrantz; Mishal Mendiratta-Lala; Brian J Bartholmai; Dhakshinamoorthy Ganeshan; Leon Lenchik; Rathan M Subramaniam
Journal:  Acad Radiol       Date:  2015-01       Impact factor: 3.173

8.  Cell membrane water exchange effects in prostate DCE-MRI.

Authors:  Xin Li; Ryan A Priest; William J Woodward; Faisal Siddiqui; Tomasz M Beer; Mark G Garzotto; William D Rooney; Charles S Springer
Journal:  J Magn Reson       Date:  2012-03-28       Impact factor: 2.229

9.  Carbogen gas and radiotherapy outcomes in prostate cancer.

Authors:  Kent Yip; Roberto Alonzi
Journal:  Ther Adv Urol       Date:  2013-02

10.  Blood oxygenation level-dependent MRI at 3T for differentiating prostate cancer from benign tissue: a preliminary experience.

Authors:  Yongtae Kim; Jung Jae Park; Chan Kyo Kim
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.